Rituximab is associated with worse COVID-19 outcomes in patients with rheumatoid arthritis: A retrospective, nationally sampled cohort study from the U.S. National COVID Cohort Collaborative (N3C)
| Title: | Rituximab is associated with worse COVID-19 outcomes in patients with rheumatoid arthritis: A retrospective, nationally sampled cohort study from the U.S. National COVID Cohort Collaborative (N3C) |
|---|---|
| Authors: | Singh, Namrata a; Madhira, Vithal b; Hu, Chen c; Olex, Amy L. d; Bergquist, Timothy e; Fitzgerald, Kathryn C. c; Huling, Jared D. f; Patel, Rena C. g; Singh, Jasvinder A. h, i, j, ⁎ |
| Source: | In Seminars in Arthritis and Rheumatism February 2023 58 |
| Database: | ScienceDirect |